Cardiac resynchronization therapy (CRT) using a biventricular pacing system has been an
effective therapeutic strategy in patients with symptomatic heart failure with a reduced left …

Objectives This study sought to describe trends in cardiovascular implantable electronic
device (CIED) insertion over the past 3 decades in Olmsted County. Background Trends in …

Aims Previous studies have identified sex disparities in the use of cardiac resynchronization
therapy (CRT) and implantable cardioverter defibrillators (ICD), although the basis of …

Background Whether outcomes differ between sexes following treatment with pacemakers
(PM), implantable cardioverter defibrillators, and cardiac resynchronization therapy (CRT) …

Background Patients with ischemic cardiomyopathy, non–left bundle branch block, or QRS
duration< 150 ms have a lower response rate to cardiac resynchronization therapy (CRT) …

Aims Cardiac resynchronization therapy (CRT) device implantation has been shown to
reduce morbidity and mortality in selected patients with heart failure. We sought to …

Aims There is a continuing debate as to whether cardiac resynchronization therapy-
defibrillation (CRT-D) is superior to CRT-pacing (CRT-P), particularly in patients with non …

Rationale Multiple clinical trials support the effectiveness of cardiac resynchronization
therapy (CRT); however, optimal patient selection remains challenging due to substantial …

Background While outcomes after de novo cardiac resynchronization therapy (CRT)
implantations have been reported, there are limited data on CRT upgrade procedures …

Objective To evaluate if there are sex and race disparities in use of implantable cardioverter-
defibrillator (ICD) devices for prevention of sudden cardiac death in patients with …